False
April 3, 2026
In the first part of a new analytical science-focused series about all things nitrosamines, five experts share their first experiences, understanding of the danger, and comparisons with other industries
By Pete Harbin
March 12, 2026
Why therapies still take years to reach the patients who need them
4 min read
March 5, 2026
PASO DOBLE sub-analysis reports steatosis differences at 96 weeks
1 min read
By Achim Link
January 28, 2026
GLP-1 peptides validated the science. CMC will validate the small molecule modality for GLP-1 efficacy, scalability, and access.
4 min read
By Stephen Tindal
January 9, 2026
Catalent offers clarification after recent discussions raised concerns around softgels, phthalates and potential health risks
3 min read
By HH Kim
January 8, 2026
A billion-dollar acquisition, breakthrough clinical data, and a shifting scientific paradigm are pushing MASH out of the shadows and into a new era of metabolic medicine.
3 min read
November 27, 2025
Check out our interview from CPHI Frankfurt featuring GELITA’s Samy Jandall
October 31, 2025
The latest New Angle report discusses the status of Europe’s antibiotics supply chain, and how structural reform at the policy level is required to rectify it.
3 min read
October 31, 2025
Texas Attorney General is suing Tylenol manufacturers, alleging misleading safety concerns and links with autism.
2 min read
October 30, 2025
October 2025 highlights in the small molecules sector include developments in dermatitis treatment, improvements in epilepsy symptoms, and the effects of amoxicillin availability.
4 min read
False